Researchers used data from the Alzheimer's Disease Neuroimaging Initiative database to identify specific brain regions associated with hyperactive neuropsychiatric symptoms among patients with mild...
Researchers examining patients with late-stage dementia and significant agitation, found that a wearable device such as a wrist-worn actigraphy could be a feasible behavior-monitoring tool to assess sleep...
Researchers set out to determine the associations between self- and partner-reported cognitive decline and tau and β-amyloid levels among cognitively unimpaired individuals.
A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
A recent cross-sectional, observational study compared the tau spread in people with Down syndrome and autosomal-dominant Alzheimer disease to identify tau-related differences between the two groups.
A retrospective cohort study comparing thick and thin liquid diets for patients with Alzheimer disease and related dementias (ADRD) and dysphagia yielded mixed results.
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
